Wellell Inc. (TPE:4106)
Taiwan · Delayed Price · Currency is TWD 24.55
+0.15 (0.61%)
Sep 18, 2026, 1:30 PM CST
Wellell Market Cap
Wellell has a market cap or net worth of 2.46 billion as of September 17, 2026. Its market cap has increased by 10.16% in one year.
Market Cap
2.46B
Enterprise Value
1.75B
Revenue
2.50B
Ranking
n/a
PE Ratio
13.34
Stock Price
24.55
ChartMarket Cap Chart
Since November 3, 2004, Wellell's market cap has increased from 972.44M to 2.46B, an increase of 153.20%. That is a compound annual growth rate of 4.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 2.46B | 10.66% |
| Dec 31, 2025 | 2.23B | -11.45% |
| Dec 31, 2024 | 2.51B | -13.84% |
| Dec 29, 2023 | 2.92B | -1.70% |
| Dec 30, 2022 | 2.97B | - |
| Dec 30, 2021 | 2.97B | 2.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WeLeader Biomedical | 3.34B |
| Apex Biotechnology | 2.99B |
| Bonraybio | 2.97B |
| Applied BioCode | 2.79B |
| A Plus Biotechnology | 2.50B |
| Dynamic Medical Technologies | 2.15B |
| Medimaging Integrated Solution | 2.05B |
| OK Biotech | 2.02B |